Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson's Disease

Curr Neuropharmacol. 2023;21(7):1464-1466. doi: 10.2174/1570159X21666221221092250.

Abstract

Quercetin, a natural antioxidant, exhibits potential neuroprotective effects by efficiently downregulating α-synuclein protein aggregation and associated neurological hallmarks, responsible for the progression of Parkinson's Disease.

Keywords: Parkinson’s disease; Quercetin; antioxidant; neuroprotective effects; α -synuclein protein; α -synuclein-associated molecular hallmarks.

Publication types

  • Editorial

MeSH terms

  • Humans
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / metabolism
  • Quercetin / pharmacology
  • Quercetin / therapeutic use
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein
  • Quercetin
  • Neuroprotective Agents